Hampton Knowles competitive analysis

Explore patent oppositions filed by Hampton Knowles against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALSAug 26, 2026
Crystal Forms Of 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-Yl)Phenyl)Amino)-N-(Methyl-D3)Pyridazine-3-CarboxamideBRISTOL MYERS SQUIBBAug 11, 2026
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEIGENEAug 5, 2026
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 29, 2026
Biopharmaceutical CompositionsGLAXOSMITHKLINEJul 15, 2026
Methods Of Reducing Particle Formation And Compositions Formed TherebyREGENERON PHARMACEUTICALSJul 8, 2026
Gas ProcessingREINERTSEN NEW ENERGYJun 19, 2026
Method For Hydrogen Production Coupled With Co2 CaptureKT TECHJun 3, 2026
Cleaner HolderLG ELECTRONICSJun 3, 2026
Compositions And Methods For Internalizing EnzymesREGENERON PHARMACEUTICALSMay 27, 2026

Latest PTAB cases involving Hampton Knowles

Discover the latest PTAB cases involving Hampton Knowles, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hampton Knowles with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HAMPTON KNOWLES40 - - -
NOVARTIS12551 - 21
REGENERON PHARMACEUTICALS55145932
SANOFI BIOTECHNOLOGY - 59 - -